Ratings for Chemours (NYSE:CC) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 0 | 2 | 2 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 1 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 2 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts have recently evaluated Chemours and provided 12-month price targets. The average target is $22.25, accompanied by a high estimate of $30.00 and a low estimate of $19.00. Observing a downward trend, the current average is 44.03% lower than the prior average price target of $39.75.
Investigating Analyst Ratings: An Elaborate Study
A comprehensive examination of how...
Login or create a forever free account to read this news
Sign up/Log in